Happy Holidays! Over 120,000 eBooks at just 19.99 each— Pick a favorite today

Springer Series in Pharmaceutical Statistics

Quantitative Decisions in Drug Development

Authors: Chuang-Stein, Christy, Kirby, Simon

  • Focuses on important decision points and evidence needed for making decisions at these points during the development of a new drug
  • Takes a holistic approach towards drug development by incorporating knowledge learned from the earlier part of the development explicitly into the decisions at later stages
  • Shows the parallel between clinical trials and diagnostic tests and how this analogy is used to emphasize the importance of replication in drug development
  • Describes how to incorporate prior knowledge into study design and decision making at different stages of drug development
  • Explains metrics useful to address the objectives of the different stages of drug development and how to compare design options based on these metrics
  • Demonstrates why over-estimation is a common problem in drug development and how adjustment should be considered to correct the over-estimation
see more benefits

Buy this book

eBook $89.00
price for USA (gross)
  • ISBN 978-3-319-46076-5
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $119.00
price for USA
  • ISBN 978-3-319-46075-8
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

This book offers a high-level treatise of evidence-based decisions in drug development. Because of the inseparable relationship between designs and decisions, a good portion of this book is devoted to the design of clinical trials. The book begins with an overview of product development and regulatory approval pathways. It then discusses how to incorporate prior knowledge into study design and decision making at different stages of drug development. The latter include selecting appropriate metrics to formulate decisions criteria, determining go/no-go decisions for progressing a drug candidate to the next stage and predicting the effectiveness of a product. Lastly, it points out common mistakes made by drug developers under the current drug-development paradigm.

The book offers useful insights to statisticians, clinicians, regulatory affairs managers and decision-makers in the pharmaceutical industry who have a basic understanding of the drug-development process and the clinical trials conducted to support drug-marketing authorization.

The authors provide software codes for select analytical approaches discussed in the book. The book includes enough technical details to allow statisticians to replicate the quantitative illustrations so that they can generate information to facilitate decision-making themselves.

About the authors

Christy Chuang-Stein was Vice President and Head of the Statistical Research and Consulting Center at Pfizer prior to retirement from the company in July 2015. She has more than 30 years of experience in the pharmaceutical industry and 160 scientific publications. She is a Fellow of the American Statistical Association (ASA) and received ASA’s Founders’ Award in 2012. She was the recipient of the Distinguished Achievement Award of the International Chinese Statistical Association in 2013.


Simon Kirby is Senior Director at the Statistical Research and Consulting Center at Pfizer. He has worked for Pfizer for more than 17 years after previously holding the position of Principal Lecturer in Statistics at Liverpool John Moores University. He has also previously worked as a Statistician at the Institute of Food Research in the UK, Rothamsted and Revlon Healthcare.

Table of contents (13 chapters)

  • Clinical Testing of a New Drug

    Chuang-Stein, Christy (et al.)

    Pages 1-18

  • A Frequentist Decision-Making Framework

    Chuang-Stein, Christy (et al.)

    Pages 19-31

  • Characteristics of a Diagnostic Test

    Chuang-Stein, Christy (et al.)

    Pages 33-40

  • The Parallel Between Clinical Trials and Diagnostic Tests

    Chuang-Stein, Christy (et al.)

    Pages 41-51

  • Incorporating Information from Completed Trials in Future Trial Planning

    Chuang-Stein, Christy (et al.)

    Pages 53-67

Buy this book

eBook $89.00
price for USA (gross)
  • ISBN 978-3-319-46076-5
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $119.00
price for USA
  • ISBN 978-3-319-46075-8
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Quantitative Decisions in Drug Development
Authors
Series Title
Springer Series in Pharmaceutical Statistics
Copyright
2017
Publisher
Springer International Publishing
Copyright Holder
Springer International Publishing AG
eBook ISBN
978-3-319-46076-5
DOI
10.1007/978-3-319-46076-5
Hardcover ISBN
978-3-319-46075-8
Series ISSN
2366-8695
Edition Number
1
Number of Pages
XV, 248
Number of Illustrations and Tables
16 b/w illustrations, 11 illustrations in colour
Topics